Sarcoidosis related to checkpoint and BRAF/MEK inhibitors in melanoma
- 1 August 2020
- journal article
- review article
- Published by Elsevier in Autoimmunity Reviews
- Vol. 19 (8) , 102587
Abstract
No abstract availableKeywords
This publication has 73 references indexed in Scilit:
- BRAF Inhibitor–Induced Antitumoral Granulomatous Dermatitis Eruption in Advanced MelanomaThe American Journal of Dermatopathology, 2015
- Combined Nivolumab and Ipilimumab or Monotherapy in Untreated MelanomaNew England Journal of Medicine, 2015
- Sarcoidosis complicating anti-cytotoxic T-lymphocyte-associated antigen-4 monoclonal antibody biotherapyEuropean Respiratory Journal, 2012
- Survival in BRAF V600–Mutant Advanced Melanoma Treated with VemurafenibNew England Journal of Medicine, 2012
- Increased Risk for Cancer Following SarcoidosisAmerican Journal of Respiratory and Critical Care Medicine, 1999
- Risk of malignant neoplasms in patients with pulmonary sarcoidosis.Thorax, 1997
- The Malignancy-Sarcoidosis SyndromeChest, 1990
- Solid tumors preceding or following sarcoidosisMedical and Pediatric Oncology, 1987
- Sarcoidosis: A Cause of Bilateral Hilary Lymphadenopathy After Excision of Malignant Melanoma of the ArmSouthern Medical Journal, 1985
- The Incidence of Malignant Tumours in Patients with Respiratory SarcoidosisBritish Journal of Cancer, 1974